600422.SS
600422.SS
CNE0000015P8
KPC PHARMACEUTICALS INC
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 6.575.214.134 8.401.447.233
21.7%
Cost of Revenue 4.042.284.632 4.750.196.536
14.9%
Gross Profit 2.532.929.501 3.651.250.697
30.6%
2.157.718.140 2.664.628.122
19.0%
Operating Income 375.211.362 986.622.575
62.0%
Pretax Income 473.557.839 934.570.238
49.3%
Net Income Common Stockholders 349.940.751 648.081.342
46.0%
-- --
--
-- --
--
ende